TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $36,915,000 | +173.2% | 490,585 | -2.5% | 0.30% | +230.4% |
Q1 2022 | $13,513,000 | -50.8% | 503,288 | -12.5% | 0.09% | -47.4% |
Q4 2021 | $27,451,000 | -20.6% | 575,488 | +10.5% | 0.18% | -25.5% |
Q3 2021 | $34,583,000 | -14.9% | 520,625 | 0.0% | 0.24% | -15.5% |
Q2 2021 | $40,620,000 | -24.0% | 520,625 | +13.9% | 0.28% | -37.5% |
Q1 2021 | $53,482,000 | -3.9% | 456,941 | -0.0% | 0.44% | +0.9% |
Q4 2020 | $55,681,000 | +171.0% | 456,946 | +94.3% | 0.44% | +128.5% |
Q3 2020 | $20,543,000 | +33.6% | 235,163 | -1.2% | 0.19% | +19.1% |
Q2 2020 | $15,378,000 | +65.4% | 238,081 | +56.0% | 0.16% | +57.3% |
Q1 2020 | $9,295,000 | -2.2% | 152,640 | +0.0% | 0.10% | +1.0% |
Q4 2019 | $9,507,000 | +666.1% | 152,628 | +362.5% | 0.10% | +537.5% |
Q3 2019 | $1,241,000 | – | 33,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,737,297 | $176,802,000 | 6.75% |
MPM BioImpact LLC | 308,686 | $19,938,000 | 5.30% |
Burrage Capital Management LLC | 77,172 | $4,985,000 | 3.49% |
Orbimed Advisors | 2,745,327 | $177,321,000 | 2.50% |
Parkman Healthcare Partners LLC | 110,318 | $7,125,000 | 2.01% |
SECTORAL ASSET MANAGEMENT INC | 284,486 | $18,375,000 | 1.69% |
First Light Asset Management, LLC | 192,829 | $12,455,000 | 1.45% |
Asymmetry Capital Management, L.P. | 22,608 | $1,460,000 | 1.12% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,236,000 | 0.74% |
Prosight Management, LP | 25,602 | $1,654,000 | 0.71% |